Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
08/2008
08/06/2008EP1075539B1 7-alkoxycoumarins as cytochrome p450 substrates
08/06/2008CN101235423A Catechin-metal tanning module and preparation method thereof
08/06/2008CN101235025A Method for preparing theaflavin
08/06/2008CN101235024A Benzodihydropyrane compounds, synthesizing method and use thereof
08/05/2008US7408077 Permanent surface modifiers
08/05/2008US7408072 Benzo[c]carbazoles, benzo[b]naphthofurans, benzo[kl]xanthenes, and benzo[kl]acridines oxo- and tertiary amine-substituted; high luminescence intensities; heat resistance, light resistance, solubility, dispersibility in resist materials; emit light in solution and in solid state
08/05/2008CA2334577C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
07/2008
07/31/2008WO2008090640A1 Oxime compound, photosensitive composition, color filter, method for production of the color filter, and liquid crystal display element
07/31/2008WO2008026078A3 19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring
07/31/2008US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine
07/31/2008US20080182203 (Phenyl or naphthyl)carbonylethyl tetramethylenesulfonium, phenyl tetramethylenesulfonium or triphenylsulfonium salts of an adamantyl, 4-10 carbon carbocyclic, or 7-oxabyicyclo[2.2.2]octan-1-yl-substituted 1-(carbonyloxy)-1,1-difluoroalkylsulfonic acid; uniform profile
07/30/2008EP1950210A1 Method for preparing fat-soluble polyphenolic derivatives and their use as antioxidants
07/30/2008EP1950209A1 Agent for treatment of circulatory failure
07/30/2008EP1948634A2 Process for selectively extracting procyanidins
07/30/2008EP1948633A2 3 -hydroxyflavone derivatives for the detection and the quantification of cell apoptosis
07/30/2008EP1948632A1 Flavone sulfates and their use as antioxidants
07/30/2008EP1054881B1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
07/30/2008CN101233125A Antitumoral compounds
07/30/2008CN100406460C Novel derivative of camptothecine, preparing method and use
07/30/2008CN100406013C Camptothecin derivatives
07/29/2008US7405310 Non-nucleoside reverse transcriptase inhibitors
07/29/2008US7405227 Treatment of cancer
07/29/2008US7405211 Therapeutic morpholino-substituted compounds
07/29/2008CA2323315C Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
07/24/2008WO2008086847A2 Synthesis of chromane derivatives in the presence of ionic liquids
07/24/2008WO2008022265A3 Plant isoflavone and isoflavanone o-methyltransferase genes
07/24/2008WO2007120364A3 Metabolites of wortmannin analogs and methods of using the same
07/24/2008US20080177094 reducing an alkyl 2,4,9-trithiaadamantane-7-carboxylate to produce 7-hydroxymethyl-2,4,9-trithiaadamantane; andoxidizing 7-hydroxymethyl-2,4,9-trithiaadamantane to produce 7-carbonyl-2,4,9-trithiaadamantane; Molecular wires having 2,4,9-trithiaadamantane surface anchors
07/24/2008US20080177093 Use of an oxidopyrylium species as an intermediate in a chemical reaction; oxidopyrylium species is generated photochemically from a 3-hydroxychromone derivative followed by 1,3-dipolar cycloaddition of the oxidopyrylium species to a dipolarophile
07/24/2008US20080177086 Sulfonamide Derivatives of Xanthene Compounds
07/24/2008US20080177073 Imidation of derivatives of anthracene-2,3:6,7-dianhydride, napthalene-1,4:5,8-dianhydride, or perylene-3,4:9,10-anhydride with primary amine to perylene-bis(dicarboximide)s, naphthalene-bis(dicarboximide)s, and anthracene-bis(dicarboximide)s and/or coronene-bis(dicarboximide)s; electronics, composites
07/24/2008US20080176931 e.g. 5,7-Bis(benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]chroman-3-yl 3-(benzyloxy)benzoate; antiproliferative, antitumor agent; reducing tumor cell growth; more potent, better bioavailability than catechin
07/24/2008US20080176930 angiography; low in color, low in sodium chloride content, and substantially free of pyridine
07/24/2008US20080176929 driven by proton electro-chemical potential; reduction of concentration of free radicals and reactive oxygen species in living cell; antiproliferative, antiinflammatory agent, antioxidant, disinfectant; wound healing, grafting; composition of antioxidant, linker, and charged lipophilic compound/peptide
07/24/2008US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability
07/24/2008US20080176830 Compounds, Compositions, and Methods
07/24/2008DE102007002410A1 Synthese von Chromanderivaten Synthesis of chroman
07/23/2008EP1947189A2 Method of vitamin production
07/23/2008EP1947095A1 Sulfonamide derivatives of xanthene compounds useful as fluorescent detection reagents
07/23/2008EP1945625A1 Photochromic spirodihydrophenanthropyrans
07/23/2008EP1945624A1 Chroman compounds as 5-ht1b antagonists
07/23/2008EP1689734B1 Flavonoid derivative
07/23/2008EP1664078B1 Process for the recovery of a phytolipid composition
07/23/2008EP1468064B1 Fragrance compound
07/23/2008CN101228148A Thermally-processed cocoa products useful for vascular health improvement
07/23/2008CN101225082A Method for extracting tea-polyphenol and separating monomer EGCG from tea
07/23/2008CN101225081A Isoflavone compound, preparation method and use thereof
07/23/2008CN101225080A Method for extracting flavone from sea-buckthorn leaves and feed stuff containing the same
07/23/2008CN101225079A Method for preparing 4-chlorine-2H-chromene derivative
07/23/2008CN101224224A Method for extracting crude flavone and flavone glycoside from ginkgo leafs
07/23/2008CN100404526C Method for extracting glycyrrhizicacid, licorice flavone and licorice polysaccharide
07/23/2008CN100404525C Process of extracting dihydromyricitrin from vine tea
07/23/2008CN100404524C High purity cnidicin and its preparation method and medicinal composition using said compound as active component
07/23/2008CN100404523C Process for extracting tea polyphenol, theanine, tea polysaccharide and tea pigment from tea
07/22/2008US7402686 Cannabinoid crystalline derivatives and process of cannabinoid purification
07/22/2008US7402299 Intracorporeal medicaments for photodynamic treatment of disease
07/22/2008CA2481246C Compounds that modulate ppar activity and methods for their preparation
07/17/2008WO2008084952A1 2-phenyl-4h-chromen-4-one and the use thereof as nematicide
07/17/2008WO2008083454A1 Process for flavonoids radiolabeling and its application on in vivo diagnosis of brain malfunctions related to benzodiazepine receiving sites
07/17/2008WO2008064826A8 Process for preparing nebivolol
07/17/2008US20080171788 N-(diaminomethylene)-9H-fluorene-2-carboxamide derivatives; dual antagonist for 5-HT2B and 5-HT7 receptors having selective binding affinities for 5-HT2B and 5-HT7 receptors; side effect reduction, nontoxic
07/17/2008US20080171123 Selected strains of Saccharomyces, Arthrobacter, Pseudomonas, Bacillus, Basidiomycetes and Fusarium can be directly used or coumarin reductase enzyme, for the biotransformation of pure coumarin or from plant extract, to dihydrocoumarin
07/16/2008CN101220039A Chiral center aza ring carbene precursor salt with camphor framework, synthesizing method and uses thereof
07/16/2008CN101220035A A kind of alkaloid, method for preparing the same and application in antineoplastic or antimicrobial aspects
07/16/2008CN101220018A Method for separating single tocopherol from mixed tocopherol
07/16/2008CN101220017A Method for purifying natural alpha-tocopherol succinic acid monoester
07/16/2008CN101220016A Method for synthesizing 4-hydroxyl coumarin and derivant thereof
07/16/2008CN101220015A Synthesis method for producing siskin isoflavonoid
07/16/2008CN101220014A Meletin with cell apoptosis inductive effect and metallic complex of glycoside compounds thereof
07/16/2008CN101220013A Method for extracting and separating meletin from Mesona Procumbens Hemsl
07/16/2008CN100402517C 9-anthrone lactone compounds, preparing method and use thereof
07/16/2008CN100402044C Method for dual-frequency ultrasonic strengthening extraction of effective constituent from vegetable drug
07/15/2008US7399872 converting cannabidiol to Delta 8 or Delta 9-tetrahydrocannabinol by mixing the diol with a catalyst and solvent and allowing the mixture to separate, removing the organic phase; and eluting the tetrahydrocannabinol from the organic phase
07/15/2008US7399854 Regents labeled with energy transfer dyes
07/15/2008US7399775 β-amyloid protein production/secretion inhibitor
07/15/2008US7399639 Sensors, and methods of making and using the same
07/10/2008US20080167483 extraction of pharmaceutically active components from plant materials
07/09/2008EP1940821A2 Novel vanilloid receptor ligands and their use for producing medicaments
07/09/2008EP1940516A2 Benzopyran and pyranopyridine derivatives as potassium channel openers
07/09/2008EP0984969B1 Fused dihydropyrans
07/09/2008CN101218221A Heat-processed products having altered monomer profiles and processes for controlling the epimerization of (-)-epicatechin and (+)-catechin in the products
07/09/2008CN101215282A Photochromic naphtho-pyrans compounds and synthetic method thereof
07/09/2008CN101215281A Isoflavone sulfonate derivatives and synthetic method thereof
07/09/2008CN101215280A Leukemia-resisting isoflavone sulfonate derivatives and synthetic method thereof
07/09/2008CN101215279A Dyestuff lignin sulfonic acid ester derivatices and preparation method thereof
07/09/2008CN101215278A Bavachin with plant epiphyte resisting activity
07/09/2008CN101215277A Two anti-cancer medicament raw material compounds
07/09/2008CN101214279A Method for extracting flavone and polysaccharide from mulberry leaf
07/09/2008CN101214269A Method for extracting and concentrating total flavones of ilex hainanensis
07/09/2008CN101214237A Pharmaceutical use of dandelion xylogen acid for inhibiting acetylcholine esterase
07/09/2008CN100400535C Adiponectin expression promoter
07/09/2008CN100400534C Aldose reductase inhibitor, preparation method and use thereof
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/09/2008CN100400514C 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides
07/08/2008US7396856 Benzopyran analogs and their use for the treatment of glaucoma
07/08/2008US7396855 Foods; skin, lipid, liver, and cardiovascular disorders; hormone dependent diseases, osteopenia, osteoporosis,and acute ovarian estrogen deficiency; biosynthesis by metabolism of isoflavone; drug delivery
07/08/2008US7396828 PI-3 kinase inhibitor prodrugs
07/03/2008WO2008079683A2 N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
07/03/2008WO2008079253A1 Hydrogenation of catmint oil
07/03/2008WO2008079252A1 Production of dihydronepetalactone by hydrogenation of nepetalactone
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 242